Cite
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.
MLA
Paquette, Miney, et al. “Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.” Journal of the American College of Cardiology, vol. 70, no. 13, Sept. 2017, pp. 1573–83. EBSCOhost, https://doi.org/10.1016/j.jacc.2017.07.793.
APA
Paquette, M., Riou França, L., Teutsch, C., Diener, H.-C., Lu, S., Dubner, S. J., Ma, C. S., Rothman, K. J., Zint, K., Halperin, J. L., Huisman, M. V., Lip, G. Y. H., & Nieuwlaat, R. (2017). Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 70(13), 1573–1583. https://doi.org/10.1016/j.jacc.2017.07.793
Chicago
Paquette, Miney, Lionel Riou França, Christine Teutsch, Hans-Christoph Diener, Shihai Lu, Sergio J Dubner, Chang Sheng Ma, et al. 2017. “Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.” Journal of the American College of Cardiology 70 (13): 1573–83. doi:10.1016/j.jacc.2017.07.793.